These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10577807)
1. Local and systemic immunotherapy in nasal allergy. Palma-Carlos AG; Palma-Carlos ML; Spínola Santos A; Santos C; Pedro E; Pregal A Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S207-11. PubMed ID: 10577807 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and mast cell activation. Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195 [TBL] [Abstract][Full Text] [Related]
3. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine. Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808 [TBL] [Abstract][Full Text] [Related]
4. Specific nasal provocation test with powder allergen. Salzano FA Allergy; 1997; 52(33 Suppl):32-5. PubMed ID: 9188946 [TBL] [Abstract][Full Text] [Related]
5. The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. Klimek L; Wolf H; Mewes T; Dormann D; Reske-Kunz A; Schnitker J; Mann W J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):47-53. PubMed ID: 9893184 [TBL] [Abstract][Full Text] [Related]
6. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis. Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684 [TBL] [Abstract][Full Text] [Related]
7. [Tryptase determination in nasal washings in patients with allergic rhinitis]. Khreisat I; Simonetta A; Attinà EL; Monasterolo G; Bertone GF; Beccaria T; Rossi RE Acta Otorhinolaryngol Ital; 1997 Feb; 17(1):22-5. PubMed ID: 9412151 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory mediators in naturally occurring rhinitis. Wilson SJ; Lau L; Howarth PH Clin Exp Allergy; 1998 Feb; 28(2):220-7. PubMed ID: 9515596 [TBL] [Abstract][Full Text] [Related]
9. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis. van Hage-Hamsten M; Johansson E; Roquet A; Peterson C; Andersson M; Greiff L; Vrtala S; Valenta R; Grönneberg R Clin Exp Allergy; 2002 Oct; 32(10):1448-53. PubMed ID: 12372124 [TBL] [Abstract][Full Text] [Related]